Primer: Soleno Therapeutics (SLNO US) - Nov 2025
Soleno Therapeutics has achieved a major milestone with the recent FDA approval of its lead drug, VYKAT™ XR (diazoxide choline extended-release...
161 Views
Biopharma Week in Review - October 14, 2024
We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A. Last week, SRRK gained from...
371 Views
Biopharma Week in Review - September 3, 2024
Last week, ALNY’s detailed ATTR cardiomyopathy data left room for competitors, with BBIO benefiting and an opening for IONS.
201 Views
No more insights